113
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care

ORCID Icon & ORCID Icon
Pages 1147-1152 | Received 29 Apr 2022, Accepted 29 Jul 2022, Published online: 24 Aug 2022

References

  • World Health Organization. Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000-2019. Geneva, World Health Organization; 2020. [cited 2022 Apr 22]. Available from: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates
  • Jensen RV, Hjortbak MV, Bøtker HE. Ischemic heart disease: an update. Semin Nucl Med. 2020 May;50:195–207.
  • Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234:16812–16823.
  • Khan MA, Hashim MJ, Mustafa H, et al. Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020 Jul 23; 12:e9349.
  • Ferreira-González I. The epidemiology of coronary heart disease. Rev Esp Cardiol (Engl Ed). 2014. Feb 67:139–144.
  • Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021 Jun;11:169–177.
  • Flores-Mateo G, Grau M, O’Flaherty M, et al. Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: españa 1988-2005 [Analyzing the coronary heart disease mortality decline in a Mediterranean population: Spain 1988-2005]. Rev Esp Cardiol. 2011 Nov;64:988–996.
  • Bauersachs R, Zeymer U, Brière JB, et al. Burden of coronary artery disease and peripheral artery disease: a literature review. Cardiovasc Ther. 2019 Nov 26;2019:8295054.
  • Kauf TL, Velazquez EJ, Crosslin DR, et al. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J. 2006;151:206–212.
  • Ioannides-Demos LL, Makarounas-Kirchmann K, Ashton E, et al. Cost of myocardial infarction to the Australian community: a prospective, multicentre survey. Clin Drug Investig. 2010;30:533–543.
  • Chen P, Zhang M, Zhang Y, et al. Economic burden of myocardial infarction combined with dyslipidemia. Front Public Health. 2021 Feb 19;9:648172.
  • Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014 Dec;20:327–337.
  • Gochi T, Matsumoto K, Amin R, et al. Cost of illness of ischemic heart disease in Japan: a time trend and future projections. Environ Health Prev Med. 2018 May 24;23:21.
  • Centers for Disease Control and Prevention (CDC). International classification of diseases, ninth revision, clinical modification (ICD-9-CM). CDC; 2015. [cited 2022 Mar 7]. Available from: https://www.cdc.gov/nchs/icd/icd9cm.htm
  • Centers for Disease Control and Prevention (CDC). International classification of diseases, Tenth Revision, Clinical Modification (ICD-10-CM). CDC; 2020. [cited 2022 Mar 7]. Available from: https://www.cdc.gov/nchs/icd/icd10cm.htm
  • Parliament of Spain. Law 14/2007, 3rd July, on biomedical research (BOE), Rev Derecho Genoma Hum. 2007 Jul 4. 2007 Jan-Jun;283–325
  • Davison BA, Metra M, Senger S, et al. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. Eur J Heart Fail. 2016 Aug;18:1041–1050.
  • Wang TKM, Grey C, Jiang Y, et al. Trends in length of stay following acute coronary syndrome hospitalisation in New Zealand 2006-2016: ANZACS-QI 32 study. N Z Med J. 2020 Jan 17;133:29–42.
  • Pinaire J, Azé J, Bringay S, et al. Hospital burden of coronary artery disease: trends of myocardial infarction and/or percutaneous coronary interventions in France 2009-2014. PLoS One. 2019 May 2;14:e0215649. • Analysis of hospitalization data
  • Barquera S, Pedroza-Tobías A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46:328–338.
  • Dalen JE, Alpert JS, Goldberg RJ, et al. The epidemic of the 20(th) century: coronary heart disease. Am J Med. 2014;127:807–812.
  • Hervella MI, Carratalá-Munuera C, Orozco-Beltrán D, et al. Trends in premature mortality due to ischemic heart disease in Spain from 1998 to 2018. Rev Esp Cardiol (Engl Ed). 2021 Oct;74:838–845. English, Spanish.
  • Leonardi S, Gragnano F, Carrara G, et al. Prognostic implications of declining hemoglobin content in patients hospitalized with acute coronary syndromes. J Am Coll Cardiol. 2021 Feb 2;77(4):375–388.
  • Rosen SE, Henry S, Bond R, et al. Sex-Specific disparities in risk factors for coronary heart disease. Curr Atheroscler Rep. 2015;17:49.
  • Brewer LC, Svatikova A, Mulvagh SL. The challenges of prevention, diagnosis and treatment of ischemic heart disease in women. Cardiovasc Drugs Ther. 2015 Aug;29:355–368.
  • Davies RE, Rier JD. Gender disparities in CAD: women and ischemic heart disease. Curr Atheroscler Rep. 2018 Sep 4;20:51.
  • Smolderen KG, Wang K, de Pouvourville G, et al. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012;43:198–207.
  • Lee VW, Lam YY, Yuen AC, et al. Direct medical cost of newly diagnosed stable coronary artery disease in Hong Kong. Heart Asia. 2013 Jan 2;5:1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.